Major Study Casts Doubt on Alzheimer’s Drugs: Are There More Effective Alternatives?
Recent scrutiny of Alzheimer’s disease treatments has intensified following a major scientific review that questions the clinical value of several widely promoted amyloid-targeting drugs. The analysis, conducted by the Cochrane Collaboration and published in April 2026, evaluated data from 17 clinical trials involving over 20,000 patients treated with seven different anti-amyloid medications over approximately 18 … Read more